We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva Pulls Bipolar Drug After Lackluster Trial Results
Teva Pulls Bipolar Drug After Lackluster Trial Results
September 6, 2013
Teva has pulled the plug on developing a new indication for its sleep disorder drug Nuvigil to treat bipolar I disorder after poor efficacy results from a final Phase III trial.